Defunct Company
Total Trials
34
As Lead Sponsor
30
As Collaborator
4
Total Enrollment
2,201
NCT00776646
Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions
Phase: N/A
Role: Collaborator
Start: May 31, 2006
Completion: Aug 31, 2006
NCT01603134
Bioequivalence Study of Allopurinol 300 mg Tablets USP Under Fasting Condition
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 30, 2007
Completion: Apr 30, 2008
NCT01603173
Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition
Start: Apr 30, 2011
Completion: Nov 30, 2011
NCT01603186
Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fed Condition
NCT01578252
Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition
Start: May 31, 2011
Completion: Sep 30, 2011
NCT01578265
Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fed Condition
NCT01577914
Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition
Start: Jul 31, 2011
NCT01557439
Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fasting Condition
Start: Feb 29, 2012
Completion: Mar 31, 2012
NCT01567501
Bioequivalence Study of Levocetirizine Dihydrochloride Tablets 5 mg Under Fed Condition
NCT01618799
Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition
Start: Mar 31, 2012
Completion: May 31, 2012
NCT01618825
Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition
NCT01722110
Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition
Start: Apr 30, 2012
Completion: Jun 30, 2012
NCT01618760
Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition
Start: May 31, 2012
NCT01735370
Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition
Completion: Jul 31, 2012
NCT01735383
Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition
NCT01722201
Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition
Start: Jun 30, 2012
Completion: Sep 30, 2012
NCT01735318
Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition
Completion: Aug 31, 2012
NCT01735344
Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition
NCT01741623
Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition
Start: Aug 31, 2012
Completion: Nov 30, 2012
NCT01744873
Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition
NCT01746719
Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition
Start: Oct 31, 2012
Completion: Dec 31, 2012
NCT01749228
Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition
NCT01827878
Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions
Completion: Oct 31, 2012
NCT01831700
Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions
NCT01827865
Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition
Start: Nov 30, 2012
NCT01831661
Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition
Start: Dec 31, 2012
Completion: Feb 28, 2013
NCT01831674
Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition
NCT01831687
Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition
Completion: Jan 31, 2013
NCT01884896
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions
Start: Feb 28, 2013
Completion: Mar 31, 2013
NCT01884857
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg
Start: Apr 30, 2013
Completion: Jun 30, 2013
NCT01884909
Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions
Completion: May 31, 2013
NCT02434211
Interventional Research in Schools - Second Part
Start: Jun 30, 2015
Completion: Dec 31, 2015
NCT04498676
50 Human Subject Repeat Insult Patch Test
Start: Jan 18, 2017
Completion: Mar 2, 2017
NCT05926115
Phenotype and Epidemiology of the Polycystic Ovary Syndrome (PCOS) in Colombia (PEP - Colombia) Study.
Start: Mar 4, 2023
Completion: Sep 30, 2023